Because it cannot be excluded that cancer patients who carry germ-line NBS1 mutations may show a specific sensitivity to treatment with ionising radiation or cytostatic drugs, as recently shown [8], systematic studies are now under way to protocol their responses to radio- and chemotherapy. This evidence concerns the gene NBN and cancer.